{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:01:28Z","timestamp":1784815288406,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.medcli.2026.107509","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T17:46:06Z","timestamp":1782582366000},"page":"107509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathologic spectrum and prognostic determinants in biopsy-proven thrombotic microangiopathy"],"prefix":"10.1016","volume":"166","author":[{"given":"Taha Enes","family":"Cetin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veysel Baran","family":"Tomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagmur","family":"Eken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betul","family":"Ogut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipek Isik","family":"Gonul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozant","family":"Helvaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulver","family":"Derici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galip","family":"Guz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Faruk","family":"Akcay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2026.107509_bib0165","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/680502","article-title":"Clinical and renal biopsy findings predicting outcome in renal thrombotic microangiopathy: a large cohort study from a single institute in China","volume":"2014","author":"Yu","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.medcli.2026.107509_bib0170","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.kint.2018.02.029","article-title":"Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome","volume":"94","author":"Schaefer","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.medcli.2026.107509_bib0175","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2215\/CJN.00050505","article-title":"Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background","volume":"1","author":"Bresin","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.medcli.2026.107509_bib0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.preghy.2018.02.007","article-title":"Thrombotic microangiopathies of pregnancy: differential diagnosis","volume":"12","author":"Gupta","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.medcli.2026.107509_bib0185","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00281-014-0416-x","article-title":"Hemolytic uremic syndrome","volume":"36","author":"Mele","year":"2014","journal-title":"Semin Immunopathol"},{"issue":"suppl 1","key":"10.1016\/j.medcli.2026.107509_bib0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ijlh.13954","article-title":"Diagnosis and treatment of thrombotic microangiopathy","volume":"44","author":"Thompson","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.medcli.2026.107509_bib0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100690","article-title":"Etiology and outcomes of kidney-limited and systemic thrombotic microangiopathy","volume":"38","author":"van Doorn","year":"2025","journal-title":"Mod Pathol"},{"key":"10.1016\/j.medcli.2026.107509_bib0200","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/j.akdh.2023.09.003","article-title":"Thrombotic microangiopathies and the kidney","volume":"31","author":"Java","year":"2024","journal-title":"Adv Kidney Dis Health"},{"key":"10.1016\/j.medcli.2026.107509_bib0205","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.ekir.2025.03.019","article-title":"Diagnostic value of biological parameters in biopsy-confirmed thrombotic Microangiopathy-MATRIX Consortium Group","volume":"10","author":"Halimi","year":"2025","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.medcli.2026.107509_bib0210","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/ndt\/gfk037","article-title":"What you should know about the work-up of a renal biopsy","volume":"21","author":"Amann","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.medcli.2026.107509_bib0215","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic microangiopathy and the kidney","volume":"13","author":"Brocklebank","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.medcli.2026.107509_bib0220","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.medcli.2026.107509_bib0225","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.kint.2020.04.020","article-title":"Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference","volume":"98","author":"Ostermann","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.medcli.2026.107509_bib0230","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14072527","article-title":"Atypical hemolytic uremic syndrome: a review of complement dysregulation genetic susceptibility and multiorgan involvement","volume":"14","author":"Bogdan","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.medcli.2026.107509_bib0235","doi-asserted-by":"crossref","DOI":"10.1111\/nep.70116","article-title":"Management of atypical haemolytic uraemic syndrome with triggers: diagnostic and treatment algorithms from an Asia-Pacific perspective","volume":"30","author":"Kang","year":"2025","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.medcli.2026.107509_bib0240","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2026.107509_bib0245","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2026.2617722","article-title":"Long-term renal outcomes of patients with biopsy-proven malignant hypertension-associated renal thrombotic microangiopathy who are dialysis-independent at baseline","volume":"48","author":"Li","year":"2026","journal-title":"Ren Fail"},{"key":"10.1016\/j.medcli.2026.107509_bib0250","first-page":"1","article-title":"Clinico-histological features of thrombotic microangiopathy in renal biopsies: a retrospective study","volume":"38","author":"Manickam","year":"2022","journal-title":"Turk Patoloji Derg"},{"key":"10.1016\/j.medcli.2026.107509_bib0255","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ekir.2017.04.008","article-title":"Effect of thrombotic microangiopathy on clinical outcomes in indian patients with lupus nephritis","volume":"2","author":"Pattanashetti","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.medcli.2026.107509_bib0260","series-title":"Heptinstalls Pathology of the Kidney","author":"Silva","year":"2014"},{"key":"10.1016\/j.medcli.2026.107509_bib0265","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.medcli.2026.107509_bib0270","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.medcli.2026.107509_bib0275","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1182\/blood.2022017860","article-title":"How I diagnose and treat atypical hemolytic uremic syndrome","volume":"141","author":"Fakhouri","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2026.107509_bib0280","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1681\/ASN.2017121260","article-title":"The prognostic value of histopathologic lesions in native kidney biopsy specimens: results from the Boston Kidney Biopsy Cohort Study","volume":"29","author":"Srivastava","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.medcli.2026.107509_bib0285","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12030758","article-title":"Is endothelial activation a critical event in thrombotic thrombocytopenic purpura?","volume":"12","author":"Cauchois","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.medcli.2026.107509_bib0290","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1681\/ASN.2015020184","article-title":"Kidney disease caused by dysregulation of the complement alternative pathway: an etiologic approach","volume":"26","author":"De Vriese","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.medcli.2026.107509_bib0295","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41581-021-00424-4","article-title":"Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics","volume":"17","author":"Fakhouri","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.medcli.2026.107509_bib0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1681\/ASN.2013050453","article-title":"Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome","volume":"25","author":"Bu","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.medcli.2026.107509_bib0305","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.medcli.2026.107509_bib0310","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2026.107509_bib0315","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00467-018-4091-3","article-title":"Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use","volume":"34","author":"Wijnsma","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.medcli.2026.107509_bib0320","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326001594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326001594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:13:51Z","timestamp":1784812431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775326001594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0025775326001594"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107509","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic spectrum and prognostic determinants in biopsy-proven thrombotic microangiopathy","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107509"}}